FINAL PROGRAM - Society for Immunotherapy of Cancer
FINAL PROGRAM - Society for Immunotherapy of Cancer
FINAL PROGRAM - Society for Immunotherapy of Cancer
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
Program Schedule<br />
FRIDAY, NOVEMBER 4, 2011<br />
11:45 am - 12:00 pm Reversal <strong>of</strong> Local Immune Evasion Mechanisms and Regression <strong>of</strong> Human Merkel Cell Carcinoma by<br />
Intralesional Injection <strong>of</strong> Interferon-Beta<br />
Kelly G. Paulson<br />
University <strong>of</strong> Washington<br />
12:00 pm - 1:30 pm Lunch with Exhibits / Poster Viewing and Presentations<br />
(Box lunches provided to registered attendees.)<br />
12:30 pm - 1:30 pm Odd Numbered Poster Presentations by Authors<br />
1:30 pm - 3:00 pm Concurrent Session I: Immunology <strong>of</strong> <strong>Cancer</strong> Stem Cells and Epithelialto-Mesenchymal<br />
Transition (EMT)<br />
Chairs:<br />
Malcolm A.S. Moore, DPhil<br />
Memorial Sloan-Kettering <strong>Cancer</strong> Center<br />
Jeffrey Schlom, PhD<br />
National <strong>Cancer</strong> Institute, NIH<br />
1:30 pm - 2:00 pm <strong>Cancer</strong> Testis (CT) Antigens Expressed in Ovarian Tumor-Initiating Cells<br />
Malcolm A.S. Moore, DPhil<br />
Memorial Sloan-Kettering <strong>Cancer</strong> Center<br />
2:00 pm - 2:30 pm Immunotherapeutic Approaches to EMT and <strong>Cancer</strong> Stem Cells<br />
Claudia M. Palena, PhD<br />
National <strong>Cancer</strong> Institute, NIH<br />
Grand Ballroom Salons A-D<br />
Grand Ballroom Salon E<br />
2:30 pm - 2:45 pm Immunological Targeting <strong>of</strong> Epithelial to Mesenchymal Transition as a Strategy to Prevent Breast <strong>Cancer</strong><br />
Metastases<br />
Sandra Demaria, MD<br />
New York University School <strong>of</strong> Medicine<br />
2:45 pm - 3:00 pm Potential <strong>for</strong> Immunotherapeutic Control <strong>of</strong> CSC-like Cells Through their Expression <strong>of</strong> FAS and DR5 Death<br />
Receptors<br />
Trina Stewart, PhD<br />
Peter MacCallum <strong>Cancer</strong> Centre<br />
1:30 pm - 3:00 pm Concurrent Session II: Uncoupling Negative Regulation in the Tumor<br />
Microenvironment<br />
Chairs:<br />
Lieping Chen, MD, PhD<br />
Yale <strong>Cancer</strong> Center, Yale School <strong>of</strong> Medicine, Immunobiology<br />
Hassane M. Zarour, MD<br />
University <strong>of</strong> Pittsburgh<br />
1:30 pm - 2:00 pm Immune Checkpoints in the <strong>Cancer</strong> Microenvironment<br />
Lieping Chen, MD, PhD<br />
Yale <strong>Cancer</strong> Center, Yale School <strong>of</strong> Medicine, Immunobiology<br />
Grand Ballroom Salons G-H<br />
2:00 pm - 2:15 pm IL-12 Triggers an Inflammatory Gene Signature that Reverses Dysfunctional Antigen-presentation by<br />
Myeloid-Derived Cells Residing within Tumors<br />
Sid Kerkar, MD<br />
National <strong>Cancer</strong> Institute, Center <strong>for</strong> <strong>Cancer</strong> Research, NIH<br />
2:15 pm - 2:30 pm Acute Myeloid Leukemia Promotes Immune Evasion through Induction <strong>of</strong> Antigen-Specific T Cell Deletion<br />
Justin P. Kline, MD<br />
University <strong>of</strong> Chicago<br />
2:30 pm - 3:00 pm Targeting Multiple Inhibitory Pathways to Reverse Melanoma-induced T Cell Dysfunction<br />
Hassane M. Zarour, MD<br />
University <strong>of</strong> Pittsburgh<br />
3:00 pm - 3:15 pm Break<br />
18<br />
<strong>FINAL</strong> <strong>PROGRAM</strong> • SITC 26 TH ANNUAL MEETING<br />
November 4-6, 2011 • North Bethesda, MD • www.sitcancer.org
Change language